Tessa Youngner: New Free E-Course Introduces Comprehensive SCD Care
Tessa Youngner, Program Coordinator, Global Hematology at St. Jude Children’s Research Hospital, shared a post on LinkedIn:
“Exciting news from the St. Jude Children’s Research Hospital Global Hematology Program – the new ‘Introduction to Sickle Cell Disease’ e-course is now live!!!
This free e-course offers providers, caregivers, and warriors evidence-based guidance on comprehensive, lifespan SCD management.
Designed as an animated story, learners will follow the life of a child born with SCD, ‘gift’, as she navigates common clinical, psychological, and social complications with the help of her health care team and caregivers.
Learners who successfully complete the course will receive a certificate of completion.
To access this free course, please:
- Register for, or log into your, Cure4Kids account.
- Enroll in the ‘Introduction to Sickle Cell Disease’ course.
We are excited to share this educational tool with our global sickle cell disease community and celebrate the great strides being made to improve care.
Happy Sickle Cell Awareness Month!!!”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning